#toxicology — Wednesday, February 04, 2026 (1 items)
| 0 | 💬 0 |
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studies.
(journals.asm.org)
|
Antimicrobial Agents and Chemotherapy 2026-02-04 | #pharmacokinetics #toxicology #malaria #clinical trial |